Literature DB >> 12738523

Hysteroscopic appearance of the endometrial cavity following thermal balloon endometrial ablation.

Pui Ling Leung1, Wing Hung Tam, Pong Mo Yuen.   

Abstract

OBJECTIVE: To assess the appearance of the endometrial cavity after thermal balloon endometrial ablation.
DESIGN: Observational study.
SETTING: University teaching hospital. PATIENT(S): Twenty-two women who had undergone thermal balloon endometrial ablation and who were followed up for at least 6 months. INTERVENTION(S): Outpatient diagnostic hysteroscopy. MAIN OUTCOME MEASURE(S): Appearance of the endometrial cavity and presence of intrauterine adhesions on hysteroscopy. RESULT(S): Postablation intrauterine adhesions were found in eight women (36.4%); six had focal adhesions in the fundal area and two had complete obliteration of the cavity. Of these eight women, three had spotting during menstruation, three had hypomenorrhea, one had eumenorrhea, and one had amenorrhea. The uterine cavity was fibrotic in four (18%) women; all reported spotting during menstruation. Ten women had a normal uterine cavity; eight had hypomenorrhea, one had spotting, and one had eumenorrhea. CONCLUSION(S): The hysteroscopic appearance of the uterine cavity after thermal balloon endometrial ablation varies considerably. Menstrual outcome is associated with postablation appearance.

Entities:  

Mesh:

Year:  2003        PMID: 12738523     DOI: 10.1016/s0015-0282(02)04956-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

Review 1.  Recent Advances in Understandings Towards Pathogenesis and Treatment for Intrauterine Adhesion and Disruptive Insights from Single-Cell Analysis.

Authors:  Ross Ka-Kit Leung; Yixin Lin; Yanhui Liu
Journal:  Reprod Sci       Date:  2020-10-30       Impact factor: 3.060

Review 2.  The management of Asherman syndrome: a review of literature.

Authors:  Alessandro Conforti; Carlo Alviggi; Antonio Mollo; Giuseppe De Placido; Adam Magos
Journal:  Reprod Biol Endocrinol       Date:  2013-12-27       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.